Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | CDC25A | P30304 | 6/20 | 0.34 |
| ▸ | CDC25B | P30305 | 6/20 | 0.34 |
| ▸ | CDC25C | P30307 | 5/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2315804 | 0.98 | ACHE (0.37) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL4629705 | 0.98 | ACHE (0.37) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL3021386 | 0.98 | ACHE (0.37) | ACHEBACE1CDC25ACDC25BCDC25C | |
| Hexanoate SCHEMBL27802806 | 0.87 | SCD (0.51) | CDC25ACDC25BCDC25CALOX15GPR84 | |
| SCHEMBL7054062 | 0.81 | CYP1A2 (0.34) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL9992284 | 0.79 | FNTA (0.37) | — | |
| SCHEMBL28600201 | 0.79 | CDC25A (0.34) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL11156027 | 0.76 | ACHE (0.37) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL9264130 | 0.74 | ACHE (0.40) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL5821421 | 0.74 | CYP1A1 (0.33) | ACHEBACE1GPR84CYP1A2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9084827-B2 | Biodegradable polyurethane/urea compositions | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2015-07-21 | — | — | US | claimed |
| US-20140099277-A1 | BIODEGRADABLE POLYURETHANE/UREA COMPOSITIONS | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2014-04-10 | — | — | US | claimed |
| US-20130150964-A1 | BIODEGRADABLE POLYURETHANE/UREA COMPOSITIONS | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2013-06-13 | — | — | US | claimed |
| US-7105628-B2 | Compositions for golf equipment | ACUSHNET COMPANY (US) | 2006-09-12 | — | — | US | claimed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
| WO-2026087386-A1 | ROSIN DIESTER COMPOUNDS AND USES THEREOF | FIRMENICH SA (CH) | 2026-04-30 | — | — | WO | disclosed |
| EP-4680039-A1 | COMPOSITIONS FOR REDUCING OFF NOTES AND USES THEREOF | DSM-Firmenich AG (CH) | 2026-01-21 | — | — | EP | disclosed |
| US-20250387310-A1 | COMPOSITIONS THAT ENHANCE THE COOLING EFFECT | FIRMENICH INCORPORATED (US) | 2025-12-25 | — | — | US | disclosed |
| EP-4661972-A1 | TASTE-MODIFYING COMPOSITIONS AND USES THEREOF | Firmenich SA (CH) | 2025-12-17 | — | — | EP | disclosed |
| WO-2025202256-A1 | COOLING COMPOSITION | FIRMENICH SA (CH) | 2025-10-02 | — | — | WO | disclosed |
| EP-4608171-A1 | NATURAL SWEETENER COMPOSITIONS CONTAINING ALKYL LACTATES AND USES THEREOF | Firmenich SA (CH) | 2025-09-03 | — | — | EP | disclosed |
| EP-3164107-B1 | LACTONE-CONTAINING COMPOSITIONS FOR MALODOR ELIMINATION | TAKASAGO PERFUMERY CO LTD (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-20040220356-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220377-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220373-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220376-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220371-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220357-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-4435329-A | ANTIHYPERTENSIVE AGENTS | AMERICAN CYANAMID COMPANY (US) | 1984-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140099277-A1 | BIODEGRADABLE POLYURETHANE/UREA COMPOSITIONS | PUF60, UMPS, COL2A1 | ACHE 4303/4885BACE1 4733/4885CDC25A 3086/4885 |
| US-20250387310-A1 | COMPOSITIONS THAT ENHANCE THE COOLING EFFECT | TAS2R30, TAS2R1, TAS2R20 | ACHE 793/4885BACE1 927/4885CDC25A 3441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.